Eseosaserea Igbinigie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eseosaserea Igbinigie has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jinping Li
Department of Biomedical Science, Mercer University School of Medicine, Savannah, GA 31404, USA
2 shared publications - Brinkley Bray
Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA
1 shared publication - Cullen Kelley
Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA
1 shared publication - Fengbiao Guo
Department of Biomedical Science, Mercer University School of Medicine, Savannah, GA 31404, USA
1 shared publication - Gang Ren
Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
1 shared publication - Hao Wu
Beijing Normal University Beijing China
1 shared publication
Latest Publications
- 1 January 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 488, 226-234
Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma
- 1 January 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 488, 226-234
Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma
- Open Access
- 19 April 2018
- Published by MDPI AG in Antibodies
- Vol. 7 (2) , 18
IgG Antibody 3D Structures and Dynamics
Antibodies are vital for human health because of their ability to function as nature’s drugs by protecting the body from infection. In recent decades, antibodies have been used as pharmaceutics for targeted therapy in patients with cancer, autoimmune diseases, and cardiovascular diseases. Capturing the dynamic structure of antibodies and characterizing antibody fluctuation is critical for gaining a deeper understanding of their structural characteristics and for improving drug development. Current techniques for studying three-dimensional (3D) structural heterogeneity and variability of proteins have limitations in ascertaining the dynamic structural behavior of antibodies and antibody-antigen complexes. Here, we review current techniques used to study antibody structures with a focus on the recently developed individual-particle electron tomography (IPET) technique. IPET, as a particle-by-particle methodology for 3D structural characterization, has shown advantages in studying structural variety and conformational changes of antibodies, providing direct imaging data for biomolecular engineering to improve development and clinical application of synthetic antibodies.
- 19 April 2018
- Published by MDPI AG in Antibodies
- Vol. 7 (2) , 18
Open AccessIgG Antibody 3D Structures and Dynamics
Antibodies are vital for human health because of their ability to function as nature’s drugs by protecting the body from infection. In recent decades, antibodies have been used as pharmaceutics for targeted therapy in patients with cancer, autoimmune diseases, and cardiovascular diseases. Capturing the dynamic structure of antibodies and characterizing antibody fluctuation is critical for gaining a deeper understanding of their structural characteristics and for improving drug development. Current techniques for studying three-dimensional (3D) structural heterogeneity and variability of proteins have limitations in ascertaining the dynamic structural behavior of antibodies and antibody-antigen complexes. Here, we review current techniques used to study antibody structures with a focus on the recently developed individual-particle electron tomography (IPET) technique. IPET, as a particle-by-particle methodology for 3D structural characterization, has shown advantages in studying structural variety and conformational changes of antibodies, providing direct imaging data for biomolecular engineering to improve development and clinical application of synthetic antibodies.